Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus

Table 2

The relations between MUC5AC immunostaining, EAI, and DAI in the UC patients with tacrolimus treatment (𝑛=18).

	MUC5AC*			EAI			Response
	(Scores)			(Scores)
	Before		After	Before		After
Case  1	1	→	0	3	→	0	Complete response
Case  2	1	→	0	3	→	0	Complete response
Case  3	1	→	0	2	→	0	Complete response
Case  4	2	→	1	3	→	0	Partial response
Case  5	2	→	1	3	→	0	Partial response
Case  6	2	→	1	2	→	0	Partial response
Case  7	1	→	0	3	→	1	Partial response
Case  8	1	→	0	2	→	1	Partial response
Case  9	1	→	0	2	→	1	Partial response
Case  10	0	→	0	3	→	1	Partial response
Case  11	0	→	0	2	→	1	Partial response
Case  12	0	→	2	3	→	2	Partial response
Case  13	3	→	3	2	→	3	Treatment failure
Case  14	2	→	2	2	→	2	Treatment failure
Case  15	1	→	2	3	→	3	Treatment failure
Case  16	1	→	1	2	→	2	Treatment failure
Case  17	1	→	0	2	→	2	Treatment failure
Case  18	0	→	3	1	→	2	Treatment failure

EAI: endoscopic activity index; DAI: disease activity index. *MUC5AC versus EAI, 𝑃=0.043 with Fischer exact probability.